biotech
2 articlesAll articles tagged "biotech"

Deep DiveGear & Lifestyle
Regeneron Pharmaceuticals: EYLEA Franchise, Dupixent Immunology, and Drug Pipeline
Regeneron Pharmaceuticals is a biotech leader built on proprietary antibody technology (VelociSuite). This explainer covers the EYLEA/EYLEA HD ophthalmology franchise, Dupixent immunology partnership with Sanofi, Libtayo oncology, pipeline diversification into obesity and gene therapy, and key risks.
May 26, 2026

Deep DiveGear & Lifestyle
Amgen: Biotech Cash Flows, Blockbuster Biologics, and Pipeline Risk
Amgen Inc. is one of the world's largest independent biotechnology companies. This explainer covers blockbuster biologics, biosimilar competition, the Horizon Therapeutics acquisition, obesity pipeline (MariTide), capital allocation, and key risks.
May 26, 2026